ECE2008 Poster Presentations Endocrine tumours (77 abstracts)
Type 1 iodothyronine deiodinase (D1) enzymatic activity is not reduced in liver focal nodular hyperplasia (FNH)
Anna Szalas 1 , Marta Stepnowska 1 , Marcin Debski 1 , Oskar Kornasiewicz 2 , Marek Krawczyk 2 & Ewa Bar-Andziak 1
1Chair and Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland; 2Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
FNH is the second most common benign liver tumor caused mainly by oral contraceptives. D1, which is a crucial enzyme in catalyzing prohormone thyroxine (T4) into active triiodothyronine (T3), is mainly present in such tissues as thyroid, liver and kidney. There are only few data about D1 enzymatic activity in neoplasmatic conditions. Mostly in tumors reduced D1 activity was found.
The aim of the study was to examine the activity of this enzyme in FNH.
Thirteen samples of the tumor and the corresponding number of healthy control tissues were collected from the patients, who underwent the surgery because of that disease. Average age was 28.3. We assessed the activity by measurement of radioactive iodine released in deiodination reaction catalyzed by D1.
We found that D1 enzymatic activity is not reduced in FNH in comparison with healthy controls (P=0.555). Our finding demonstrates that not every type of neoplasm presents low D1 activity.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more